Related Experiment Videos
Clinical spectrum and outcomes of autoimmune hepatitis in children: a quaternary centre experience
Nazia Iqbal1, Iqtadar Seerat1, Sobia Noureen1
1Department of Paediatric Gastroenterology and Hepatology, Pakistan Kidney and Liver Institute and Research Centre, Lahore, Pakistan.
Insights
This study analyzed pediatric autoimmune hepatitis outcomes, revealing jaundice as the most common symptom and highlighting significant challenges in diagnosis and treatment for children. Further research is needed to improve patient care.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
- Immunology
Background:
- Autoimmune hepatitis (AIH) in children presents unique challenges.
- Understanding disease spectrum and outcomes is crucial for effective management.
Purpose of the Study:
- To analyze pediatric autoimmune hepatitis severity, treatment response, and clinical outcomes.
- To assess progression to liver failure and transplant survival in children.
Main Methods:
- A retro-prospective study of pediatric patients (<15 years) diagnosed with AIH.
- Data collected on demographics, clinical features, labs, and imaging.
- Statistical analysis using SPSS 27.
Main Results:
- 56 children studied; 53.6% were girls. Predominant type was AIH-1 (82.1%).
- Jaundice (96.4%) was the most common symptom, followed by ascites (50%).
- 8 (14.3%) patients required liver transplantation; hepatocyte rosette formation noted on biopsy.
Conclusions:
- Pediatric autoimmune hepatitis exhibits significant clinical variability.
- Diagnostic and therapeutic challenges persist, necessitating improved strategies.
- Outcomes analysis underscores the need for advanced pediatric liver disease care.
Objective:
To analyse paediatric autoimmune hepatitis with respect to disease severity, treatment response, and clinical outcomes, including progression to liver failure and transplant survival.
Methods:
The retro-prospective study was conducted at the Pakistan Kidney and Liver Institute and Research Centre, Lahore, Pakistan, and comprised data from July 2019 to December 2024 of paediatric patients aged <15 years diagnosed with autoimmune hepatitis. Demographic characteristics, clinical manifestations as well as laboratory and imaging findings were noted. Data was analysed using SPSS 27.
Results:
Of the 56 patients, 30(53.6%) were girls with mean age 9.94±2.63 years, and 26(46.4%) were boys with mean age 9.24±2.90 years. Autoimmune hepatitis type 1 was the predominant type 46(82.1%), while type 2 was found in 1(1.8%) patient and 9(16.1%) were seronegative. Jaundice was the most common symptom found in 54(96.4%) followed by ascites 28(50%) and abdominal pain 18(32.1%). Histopathology of liver biopsies revealed features consistent with autoimmune hepatitis including statistically significant hepatocyte rosette formation (p value= 0.100). Overall, 8 (14.3%) patients required liver transplantation.
Conclusion:
The clinical spectrum of autoimmune hepatitis and its outcomes in children indicated there were significant diagnostic and therapeutic challenges that needed to be overcome.
Related Concept Videos
Viral Hepatitis I: Introduction
Hepatitis
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Pancreatitis II: Collaborative Care
Assessment: